News
Ojemda

Ipsen builds again, licensing Day One glioma drug

Ipsen has signed yet another portfolio-expanding deal – its fifth of the year so far – claiming rights outside the US to a drug for common brain cancer glioma from Day One Biopharmaceutical

News

News
Ojemda

Ipsen builds again, licensing Day One glioma drug

Ipsen has signed yet another portfolio-expanding deal – its fifth of the year so far – claiming rights outside the US to a drug for common brain cancer glioma from Day One Biopharmaceutical

Press Releases

Views & Analysis

Sales & Marketing
12 Questions with Irina Spirieva
Sponsored

12 Questions with Irina Spirieva

Irina Spirieva started her career in fast-moving consumer goods working in brand management for AB-InBev and Heineken.

Sales & Marketing
12 Questions with Dr James Burt
Sponsored

12 Questions with Dr James Burt

James Burt, CEO of Pharmanovia, is a seasoned leader focused on driving innovation in the value-added medicines (VAMs) space.

Newsletters and Deep Dive
digital magazine

Deep Dive

Sales & Marketing
A pharma industry event round-up: Insights and trends

A pharma industry event round-up: Insights and trends

From artificial intelligence and digital therapeutics to the latest in oncological research and RNA therapeutics, from developments in the CNS field to what’s what in customer experience an

Webinars

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png
Sales & Marketing
Upscaling your brand strategy game with new ways of planning
Sponsored

Take pharma brand planning to the next level in 2024

Today, pharma brand planning teams can benefit from technology platforms that aggregate data and automate analyses, helping unlock insights on the market landscape and clinical environment

Podcasts

Sales & Marketing
pharmaphorum podcast episode 90
Sponsored

Changing personnel dynamics in the pharma world

An economic downturn always has effects that reverberate across an industry, and perhaps one of the most visible reverberations is in the realm of personnel - more layoffs and less hiring a

White Papers

Sales & Marketing
Launch Excellence: Moments of Truth
Sponsored

Launch Excellence: Moments of Truth

The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.

Event

Debates & Insight

Debates & Insight
Digital-HCP-engagement-1200x675
Sponsored

How to optimise pharma’s digital HCP engagement

Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if they are to bridge the gap between the value a compan

Partner Content